{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:12:30Z","timestamp":1786605150472,"version":"build-2736575974"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009620","name":"gansu sheng kexue jishu ting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011136","name":"Lanzhou Veterinary Research Institute State Key Laboratory for Animal Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cellin.2024.100163","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T06:20:33Z","timestamp":1710570033000},"page":"100163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Optimizing antigen selection for the development of tuberculosis vaccines"],"prefix":"10.1016","volume":"3","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-5122","authenticated-orcid":false,"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellin.2024.100163_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/eji.200324659","article-title":"Mycobacterium vaccae induces a population of pulmonary Cd11c+ cells with regulatory potential in allergic mice","volume":"34","author":"Adams","year":"2004","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01608","article-title":"Evaluation of Aggregated Ag85b antigen for its Biophysical Properties, immunogenicity, and vaccination potential in a murine model of tuberculosis infection","volume":"8","author":"Ahmad","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2004.02609.x","article-title":"In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis","volume":"138","author":"Al-Attiyah","year":"2004","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/IAI.68.2.767-778.2000","article-title":"Disruption of the genes encoding antigen 85a and antigen 85b of Mycobacterium tuberculosis H37rv: Effect on growth in culture and in macrophages","volume":"68","author":"Armitige","year":"2000","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"Who's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cellin.2024.100163_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1054\/tuld.1998.0196","article-title":"Immunogenicity and protective efficacy of Dna vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85a","volume":"79","author":"Baldwin","year":"1999","journal-title":"Tubercle and Lung Disease"},{"key":"10.1016\/j.cellin.2024.100163_bib7","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib8","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.vaccine.2014.05.042","article-title":"Causes of variation in Bcg vaccine efficacy: Examining evidence from the bcg revac cluster randomized trial to explore the masking and the blocking hypotheses","volume":"32","author":"Barreto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"Belisle","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cellin.2024.100163_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000507","article-title":"Systematic genetic nomenclature for type Vii secretion systems","volume":"5","author":"Bitter","year":"2009","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.cellin.2024.100163_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jctube.2019.100141","article-title":"Phase Iii, placebo-controlled, randomized, double-blind trial of tableted, therapeutic Tb vaccine (V7) containing heat-killed M. vaccae administered daily for one month","volume":"18","author":"Bourinbaiar","year":"2020","journal-title":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib12","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/IAI.00520-12","article-title":"Mpra and Dosr coregulate a Mycobacterium tuberculosis virulence operon encoding Rv1813c and Rv1812c","volume":"80","author":"Bretl","year":"2012","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tim.2004.09.007","article-title":"Esat-6 proteins: Protective antigens and virulence factors?","volume":"12","author":"Brodin","year":"2004","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.cellin.2024.100163_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"Ruti: A new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cellin.2024.100163_bib15","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2004.09.008","article-title":"Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis","volume":"23","author":"Cardona","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/423938","article-title":"Regions of high antigenicity within the hypothetical Ppe major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis","volume":"190","author":"Chakhaiyar","year":"2004","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100029","article-title":"Emerging Sars-Cov-2 variants: Why, how, and what's next?","volume":"1","author":"Chen","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100163_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus calmette-guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.cellin.2024.100163_bib19","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/j.vaccine.2016.04.060","article-title":"Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains","volume":"34","author":"Condit","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib20","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S1473-3099(22)00222-5","article-title":"Safety and immunogenicity of Vpm1002 versus bcg in South African newborn babies: A randomised, phase 2 non-inferiority double-blind controlled trial","volume":"22","author":"Cotton","year":"2022","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib21","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1371\/journal.pntd.0000744","article-title":"Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa","volume":"4","author":"De Jong","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib22","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.070","article-title":"The biology of mycobacterium tuberculosis infection","volume":"5","author":"Delogu","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cellin.2024.100163_bib23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1462-5822.2007.00892.x","article-title":"The Esat6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression","volume":"9","author":"Derrick","year":"2007","journal-title":"Cellular Microbiology"},{"key":"10.1016\/j.cellin.2024.100163_bib24","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","article-title":"Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family","volume":"67","author":"Dillon","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/eji.201848071","article-title":"Mycobacterium tuberculosis Ppe18 protein inhibits Mhc class Ii antigen presentation and B cell response in mice","volume":"51","author":"Dolasia","year":"2021","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib26","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1128\/IAI.02145-14","article-title":"Protection against Mycobacterium leprae infection by the Id83\/Gla-Se and Id93\/Gla-Se vaccines developed for tuberculosis","volume":"82","author":"Duthie","year":"2014","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1365-2958.2011.07792.x","article-title":"The Mycobacterium tuberculosis Ag85a is a novel diacylglycerol acyltransferase involved in lipid body formation","volume":"81","author":"Elamin","year":"2011","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.cellin.2024.100163_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00611-19","article-title":"Dynamics of Mycobacterium tuberculosis Ag85b revealed by a sensitive enzyme-linked immunosorbent assay","volume":"10","author":"Ernst","year":"2019","journal-title":"Mbio"},{"key":"10.1016\/j.cellin.2024.100163_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102054","article-title":"Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37rv","volume":"127","author":"Fatma","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cellin.2024.100163_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/trstmh\/trw016","article-title":"Tb vaccine development and the end Tb strategy: Importance and current status","volume":"110","author":"Fletcher","year":"2016","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.cellin.2024.100163_bib31","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1038\/cddis.2014.394","article-title":"Mycobacterium tuberculosis Esat-6 is a leukocidin causing Ca2+ influx, necrosis and neutrophil extracellular trap formation","volume":"5","author":"Francis","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.cellin.2024.100163_bib32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1098\/rstb.2011.0316","article-title":"Host-pathogen coevolution in human tuberculosis","volume":"367","author":"Gagneux","year":"2012","journal-title":"Philosophical Transactions of the Royal Society of London B Biological Sciences"},{"key":"10.1016\/j.cellin.2024.100163_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrg3664","article-title":"Genomic insights into tuberculosis","volume":"15","author":"Galagan","year":"2014","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/j.cellin.2024.100163_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.icb.7100117","article-title":"Mycobacterium tuberculosis secretory proteins Cfp-10, Esat-6 and the Cfp10:Esat6 complex inhibit lipopolysaccharide-induced Nf-kappab transactivation by downregulation of reactive oxidative species (Ros) production","volume":"86","author":"Ganguly","year":"2008","journal-title":"Immunology & Cell Biology"},{"key":"10.1016\/j.cellin.2024.100163_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14760584.2019.1582338","article-title":"Recombinant influenza A viruses as vaccine vectors","volume":"18","author":"Gerlach","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cellin.2024.100163_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2148-6-95","article-title":"Evolution and expansion of the Mycobacterium tuberculosis Pe and Ppe multigene families and their association with the duplication of the Esat-6 (esx) gene cluster regions","volume":"6","author":"Gey Van Pittius","year":"2006","journal-title":"BMC Evolutionary Biology"},{"key":"10.1016\/j.cellin.2024.100163_bib37","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/21645515.2018.1458806","article-title":"The current status, challenges, and future developments of new tuberculosis vaccines","volume":"14","author":"Gong","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.cellin.2024.100163_bib38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/21645515.2018.1458806","article-title":"The current status, challenges, and future developments of new tuberculosis vaccines","volume":"14","author":"Gong","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.cellin.2024.100163_bib39","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3389\/fimmu.2017.01803","article-title":"Mtbvac: Attenuating the human pathogen of tuberculosis (Tb) toward a promising vaccine against the Tb epidemic","volume":"8","author":"Gonzalo-Asensio","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vaccine.2010.10.022","article-title":"Higher human Cd4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease","volume":"29","author":"Govender","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.mehy.2011.11.022","article-title":"The Cfp10\/Esat6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection","volume":"78","author":"Guo","year":"2012","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.cellin.2024.100163_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100005","article-title":"Single-cell transcriptomic landscape identifies the expansion of peripheral blood monocytes as an indicator of Hiv-1-Tb co-infection","volume":"1","author":"Guo","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100163_bib43","doi-asserted-by":"crossref","DOI":"10.4103\/ijmy.ijmy_98_17","article-title":"Humoral immune responses in mice immunized with region of difference dna vaccine constructs of pumvc6 and pumvc7","volume":"6","author":"Hanif","year":"2017","journal-title":"The International Journal of Mycobacteriology"},{"key":"10.1016\/j.cellin.2024.100163_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104897","article-title":"Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates","volume":"99","author":"Ishida","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellin.2024.100163_bib45","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20041690","article-title":"Cytolytic Cd8+ T cells recognizing Cfp10 are recruited to the lung after Mycobacterium tuberculosis infection","volume":"200","author":"Kamath","year":"2004","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2024.100163_bib46","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.1500981","article-title":"Role of B Cells in mucosal vaccine-induced protective Cd8+ T cell immunity against pulmonary tuberculosis","volume":"195","author":"Khera","year":"2015","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168521","article-title":"Immunogenicity and protective efficacy of the dar-901 booster vaccine in a murine model of tuberculosis","volume":"11","author":"Lahey","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2024.100163_bib48","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Guerin","volume":"22","author":"Lange","year":"2022","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28083342","article-title":"A\u00a0review of the development of multitarget molecules against hiv-Tb coinfection pathogens","volume":"28","author":"Leite","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.cellin.2024.100163_bib50","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10096-020-03843-6","article-title":"Tuberculosis vaccine development: From classic to clinical candidates","volume":"39","author":"Li","year":"2020","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib51","article-title":"Preventive effects of Mycobacterium tuberculosis Dna vaccines on the mouse model with latent tuberculosis infection","volume":"14","author":"Liang","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/hgtb.2018.211","article-title":"Immunogenicity and therapeutic effects of latency-associated genes in a Mycobacterium tuberculosis reactivation mouse model","volume":"30","author":"Liang","year":"2019","journal-title":"Human Gene Therapy Methods"},{"key":"10.1016\/j.cellin.2024.100163_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of Bcg to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cellin.2024.100163_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jmii.2014.03.005","article-title":"Recombinant tuberculosis vaccine Aec\/Bc02 induces antigen-specific cellular responses in mice and protects Guinea pigs in a model of latent infection","volume":"48","author":"Lu","year":"2015","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"key":"10.1016\/j.cellin.2024.100163_bib55","first-page":"10","article-title":"Therapeutic effect of subunit vaccine aec\/bc02 on Mycobacterium tuberculosis post-chemotherapy relapse using a latent infection murine model","author":"Lu","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.cellin.2024.100163_bib56","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:Ic31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3201\/eid2505.180208","article-title":"Mycobacterium obuense bacteremia in a patient with pneumonia","volume":"25","author":"Luis","year":"2019","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib58","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis Bcg and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.cellin.2024.100163_bib59","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1742-4658.2010.07958.x","article-title":"Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37rv","volume":"278","author":"Mahmood","year":"2011","journal-title":"FEBS Journal"},{"key":"10.1016\/j.cellin.2024.100163_bib60","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.174.6.3570","article-title":"Influence of Esat-6 secretion system 1 (Rd1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system","volume":"174","author":"Majlessi","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01232-23","article-title":"Phosphorylation of Cfp10 modulates Mycobacterium tuberculosis virulence","author":"Malakar","year":"2023","journal-title":"Mbio"},{"key":"10.1016\/j.cellin.2024.100163_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01066-23","article-title":"A\u00a0Mycobacterium tuberculosis effector targets mitochondrion, controls energy metabolism, and limits cytochrome c exit","volume":"11","author":"Martin","year":"2023","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.cellin.2024.100163_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172691","article-title":"Mrna vaccines: a new opportunity for malaria, tuberculosis and Hiv","volume":"14","author":"Matarazzo","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib64","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1002\/elps.200305601","article-title":"Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37rv and attenuated M. bovis Bcg Copenhagen","volume":"24","author":"Mattow","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cellin.2024.100163_bib65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2172-11-18","article-title":"Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis","volume":"11","author":"Mcnamara","year":"2010","journal-title":"BMC Immunology"},{"issue":"Suppl 1","key":"10.1016\/j.cellin.2024.100163_bib66","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2172-14-S1-S5","article-title":"Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guerin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens","volume":"14","author":"Mohamud","year":"2013","journal-title":"BMC Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib67","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s10875-013-9949-3","article-title":"A\u00a0randomized, controlled dose-finding Phase Ii study of the M72\/As01 candidate tuberculosis vaccine in healthy Ppd-positive adults","volume":"33","author":"Montoya","year":"2013","journal-title":"Journal of Clinical Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib68","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of Bcg vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clinical Microbiology and Infections"},{"key":"10.1016\/j.cellin.2024.100163_bib69","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.4049\/jimmunol.1000773","article-title":"The Ppe18 protein of Mycobacterium tuberculosis inhibits Nf-kappab\/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein","volume":"186","author":"Nair","year":"2011","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib70","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.4049\/jimmunol.0901367","article-title":"The Ppe18 of Mycobacterium tuberculosis interacts with Tlr2 and activates Il-10 induction in macrophage","volume":"183","author":"Nair","year":"2009","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine ruti: Randomized, placebo-controlled phase ii clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2024.100163_bib72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: A memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cellin.2024.100163_bib73","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1128\/JB.187.19.6603-6611.2005","article-title":"Fbpa-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis","volume":"187","author":"Nguyen","year":"2005","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.cellin.2024.100163_bib74","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1473-3099(16)30139-6","article-title":"Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action","volume":"17","author":"Olea-Popelka","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bmb\/ldh047","article-title":"Multidrug-resistant tuberculosis (mdr-Tb): Epidemiology, prevention and treatment","volume":"73\u201374","author":"Ormerod","year":"2005","journal-title":"British Medical Bulletin"},{"key":"10.1016\/j.cellin.2024.100163_bib76","volume":"2","author":"Pai","year":"2016","journal-title":"Tuberculosis. Nat Rev Dis Primers"},{"key":"10.1016\/j.cellin.2024.100163_bib77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0966-842X(02)02345-4","article-title":"The Esat-6\/Wxg100 superfamily -- and a new Gram-positive secretion system?","volume":"10","author":"Pallen","year":"2002","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.cellin.2024.100163_bib78","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"Mrna vaccines for Covid-19: what, why and how","volume":"17","author":"Park","year":"2021","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.cellin.2024.100163_bib79","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ni1468","article-title":"Direct extracellular interaction between the early secreted antigen Esat-6 of Mycobacterium tuberculosis and Tlr2 inhibits Tlr signaling in macrophages","volume":"8","author":"Pathak","year":"2007","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib80","doi-asserted-by":"crossref","first-page":"24508","DOI":"10.1074\/jbc.M111.234062","article-title":"The Mycobacterium tuberculosis early secreted antigenic target of 6 kda inhibits T cell interferon-gamma production through the p38 mitogen-activated protein kinase pathway","volume":"286","author":"Peng","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cellin.2024.100163_bib81","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.meegid.2017.09.023","article-title":"Conservation in gene encoding Mycobacterium tuberculosis antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa","volume":"55","author":"Perez-Martinez","year":"2017","journal-title":"Infection, Genetics and Evolution"},{"key":"10.1016\/j.cellin.2024.100163_bib82","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2958.2002.02953.x","article-title":"Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis","volume":"44","author":"Puech","year":"2002","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.cellin.2024.100163_bib83","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/314640","article-title":"Human T cell responses to the Esat-6 antigen from Mycobacterium tuberculosis","volume":"179","author":"Ravn","year":"1999","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib84","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1038\/sj.emboj.7600732","article-title":"Structure and function of the complex formed by the tuberculosis virulence factors Cfp-10 and Esat-6","volume":"24","author":"Renshaw","year":"2005","journal-title":"Embo J"},{"key":"10.1016\/j.cellin.2024.100163_bib85","doi-asserted-by":"crossref","first-page":"d5974","DOI":"10.1136\/bmj.d5974","article-title":"How does the level of Bcg vaccine protection against tuberculosis fall over time?","volume":"343","author":"Rodrigues","year":"2011","journal-title":"Bmj"},{"issue":"Suppl","key":"10.1016\/j.cellin.2024.100163_bib86","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.rvsc.2014.02.009","article-title":"Overview and phylogeny of Mycobacterium tuberculosis complex organisms: Implications for diagnostics and legislation of bovine tuberculosis","volume":"97","author":"Rodriguez-Campos","year":"2014","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.cellin.2024.100163_bib87","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13567-019-0702-7","article-title":"Evaluation of the immunogenicity and efficacy of Bcg and Mtbvac vaccines using a natural transmission model of tuberculosis","volume":"50","author":"Roy","year":"2019","journal-title":"Veterinary Research"},{"key":"10.1016\/j.cellin.2024.100163_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis vaccine development: Progress in clinical evaluation","volume":"33","author":"Sable","year":"2019","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.cellin.2024.100163_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228381","article-title":"The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins","volume":"15","author":"Safar","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2024.100163_bib90","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000525136","article-title":"The effect of delivery systems on the induction of T helper 1 cell response to an esat6-like protein Rv3619c and identification of its immunodominant peptides","volume":"31","author":"Safar","year":"2022","journal-title":"Medical Principles and Practice"},{"key":"10.1016\/j.cellin.2024.100163_bib91","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41467-023-36789-2","article-title":"Safety and immunogenicity of a thermostable Id93 + Gla-Se tuberculosis vaccine candidate in healthy adults","volume":"14","author":"Sagawa","year":"2023","journal-title":"Nature Communications"},{"issue":"Suppl 1","key":"10.1016\/j.cellin.2024.100163_bib92","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/S1472-9792(09)70017-4","article-title":"Mycobacterium tuberculosis Esx-1 system-secreted protein Esat-6 but not Cfp10 inhibits human T-cell immune responses","volume":"89","author":"Samten","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cellin.2024.100163_bib93","article-title":"Human immunology of tuberculosis","volume":"4","author":"Scriba","year":"2016","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.cellin.2024.100163_bib94","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/s41598-017-03514-1","article-title":"Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category Ii pulmonary tuberculosis in a randomized trial","volume":"7","author":"Sharma","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.cellin.2024.100163_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087439","article-title":"Preclinical evaluation of Tb\/Flu-04l-An intranasal influenza vector-based boost vaccine against tuberculosis","volume":"24","author":"Shurygina","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.cellin.2024.100163_bib96","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72f, delivered as naked dna or recombinant Protein1","volume":"172","author":"Skeiky","year":"2004","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.cellin.2024.100163_bib97","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib98","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/iai.65.11.4525-4530.1997","article-title":"Immunization with heat-killed Mycobacterium vaccae stimulates Cd8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis","volume":"65","author":"Skinner","year":"1997","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib99","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1586\/14760584.2014.929947","article-title":"Human type 5 adenovirus-based tuberculosis vaccine: Is the respiratory route of delivery the future?","volume":"13","author":"Smaill","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cellin.2024.100163_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004446","article-title":"The Esat-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (beta2m) affecting antigen presentation function of macrophage","volume":"10","author":"Sreejit","year":"2014","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.cellin.2024.100163_bib101","first-page":"1","article-title":"Guidelines for the treatment of latent tuberculosis infection: Recommendations from the national tuberculosis controllers association and cdc, 2020","volume":"69","author":"Sterling","year":"2020","journal-title":"Morbidity and Mortality Weekly Report Recommendations and Reports"},{"key":"10.1016\/j.cellin.2024.100163_bib102","series-title":"The effect evaluation on Mycobacterium vaccae in the prophylactic treatment for latent tuberculosis infection","author":"Sun Zhaoping","year":"2013"},{"key":"10.1016\/j.cellin.2024.100163_bib103","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/as01(E) vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2024.100163_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase ii, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.cellin.2024.100163_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176784","article-title":"Multi-subunit Bcg booster vaccine Gamtbvac: Assessment of immunogenicity and protective efficacy in murine and Guinea pig Tb models","volume":"12","author":"Tkachuk","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2024.100163_bib106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.cellin.2024.100163_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221837","article-title":"Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate","volume":"15","author":"Tucci","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2024.100163_bib108","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"Who's new end Tb strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cellin.2024.100163_bib109","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1016\/j.vaccine.2023.04.003","article-title":"Immunogenicity and efficacy analyses of Epc002, Eca006, and Epcp009 protein subunit combinations as tuberculosis vaccine candidates","volume":"41","author":"Wang","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/IAI.02493-14","article-title":"Cfp-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor","volume":"83","author":"Welin","year":"2015","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2024.100163_bib111","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.vaccine.2019.10.102","article-title":"A\u00a0phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, Chadox1 85a prime - mva85a boost in healthy UK adults","volume":"38","author":"Wilkie","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cellin.2024.100163_bib112","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12879-023-08092-4","article-title":"Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: A systematic review of randomised controlled clinical trials","volume":"23","author":"Wilson","year":"2023","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.cellin.2024.100163_bib113","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1021\/pr1005873","article-title":"Proteomic definition of the cell wall of Mycobacterium tuberculosis","volume":"9","author":"Wolfe","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.cellin.2024.100163_bib114","article-title":"Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: A meta-analysis","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2024.100163_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100104","article-title":"Combatting persister cells: The daunting task in post-antibiotics era","volume":"2","author":"Zhou","year":"2023","journal-title":"Cell Insight"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277289272400018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277289272400018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T09:45:27Z","timestamp":1712655927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277289272400018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S277289272400018X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2024.100163","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing antigen selection for the development of tuberculosis vaccines","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2024.100163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100163"}}